Affiliated with a Castle Connolly Top Hospital
Who is Dr. Hancock, Radiation Oncologist in Palo Alto, CA?
Dr. Steven Hancock, MD is a Radiation Oncologist, who primarily practices in Palo Alto, CA with 1 additional practice location. He is board certified. Dr. Hancock completed his residency at Stanford Univ Hosp, Therapeutic Radiology Stanford Univ Hosp, Flexible Or Transitional Year. Dr. Hancock is fluent in English, and is currently seeing new patients. Dr. Hancock’s practice accepts Medicare, Aetna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Hancock’s office at (650) 723-3391.
What are Areas of Expertise for Dr. Hancock?
Dr. Steven Hancock, MD is a highly-rated, board-certified Radiation Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Hancock empowers patients to confidently navigate their health journey, specializing in Central Nervous System Cancer, Clinical Trials, Genitourinary Cancer, Prostate Cancer, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Hancock is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Hancock go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Therapeutic Radiology Stanford Univ Hosp, Flexible Or Transitional Year | Stanford University School of Medicine
Medical School: Stanford Univ Sch Of Med- Stanford Ca
Is Dr. Hancock board certified as a Radiation Oncologist?
Yes, Dr. Steven Hancock, MD is board certified by the American Board of Radiology since 1982, American Board of Internal Medicine since 1980, American Board of Internal Medicine
What languages does Dr. Hancock speak?
Dr. Hancock and their clinical team can communicate with patients in the following languages:
English
What conditions does a Radiation Oncologist like Dr. Hancock typically treat?
As a Radiation Oncologist, Dr. Hancock diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Hancock. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Secondary Bone Cancer
- Secondary Brain Cancer
- Bone Cancer
- Brain Tumor
- Metastatic bone cancer
- Cancer spread to bone
- Bone metastases
- Metastatic brain cancer
- Brain metastases
- Cancer spread to brain
ICD-10 Codes:
- C7951: Secondary malignant neoplasm of bone
- C7931: Secondary malignant neoplasm of brain
Also known as:
- Benign Meningioma
- Benign Tumor
- Brain Disease
- Non-cancerous brain lining tumor
- Brain membrane tumor
- Cerebral meningeal tumor
ICD-10 Codes:
- D320: Benign neoplasm of cerebral meninges
Also known as:
- Secondary Cancer in Head and Neck Lymph Nodes
- Cancer
- Metastatic Cancer to Neck Lymph Nodes
- Head and Neck Lymph Node Cancer Spread
- Lymph Node Metastasis in Neck
ICD-10 Codes:
- C770: Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
What procedures does a Radiation Oncologist like Dr. Hancock typically perform?
As a Radiation Oncologist, procedures performed by Dr. Steven Hancock may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
Please contact Dr. Hancock's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Hancock accept my insurance?
Dr. Hancock accepts most major insurance plans. Important: Please call our office at (650) 723-3391 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Hancock accept in Palo Alto, CA?
Dr. Hancock in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
Blue Cross Blue Shield
Medicare
UnitedHealth Group
UnitedHealthcare
View All Insurances
Where is Dr. Hancock's office located?
Recognitions
Publications
Automatic prostate tracking
, 2013
Testicular Cancer Clinical Practice Guidelines in Oncology
, 2012
NCCN Clinical Practice Guidelines in Oncology for Kidney Cancer
, 2011
Testicular Cancer
, 2009
Kidney Cancer
, 2009
Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's
, 2008
Radiotherapy after prostatectomy
, 2007
A study of the accuracy of cyberknife spil radiosurgery using skeletal structure tracking.
, 2007
Screening for corory artery disease after mediastil irradiation for Hodgkin's disease
, 2007
Testicular cancer. Clinical practice guidelines in oncology.
, 2006
Kidney cancer. Clinical practice guidelines in oncology.
, 2006
Breast cancer screening in women surviving Hodgkin disease
, 2006
Clinical manifestations of noncorory atherosclerotic vascular disease after moderate dose
, 2006
Diastolic dysfunction after mediastil irradiation
, 2005
Report from the Rockefellar Foundation Sponsored Intertiol Workshop on reducing mortality
, 2005
Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes
, 2005
Testicular cancer. Clinical practice guidelines.
, 2005
Kidney cancer. Clinical practice guidelines.
, 2005
Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes?
, 2004
Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy
, 2004
Asymptomatic cardiac disease following mediastil irradiation
, 2003
Role of beam orientation optimization in intensity-modulated radiation therapy
, 2001
Magement of breast cancer after Hodgkin's disease
, 2000
Fractioted stereotactic radiosurgery
, 1999
The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
, 1999
Radiation therapy for clinically localized prostate cancer - A multi-institutiol pooled alysis
, 1999
Acute hearing loss following fractioted stereotactic radiosurgery for acoustic neuroma
, 1998
Effect of combined transient androgen deprivation and irradiation following radical prostatectomy
, 1998
Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
, 1998
Node-positive prostatic cancer: Taps or a call to arms?
, 1998
Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease
, 1997
Gastrointestil cancer after treatment of Hodgkin's disease
, 1997
The cyberknife: A frameless robotic system for radiosurgery
, 1997
Linear accelerator-based stereotaxic radiosurgery for brain metastases
, 1996
Second cancers after Hodgkin's disease in childhood
, 1996
Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
, 1996
PROSTATE-SPECIFIC ANTIGEN AFTER RADIOTHERAPY FOR PROSTATE
, 1995
BRIEF CHEMOTHERAPY, STANFORD-V
, 1995
STEM-CELL FACTOR ENHANCES THE SURVIVAL OF MURINE INTESTIL STEM-CELLS AFTER PHOTON IRRADIATION
, 1995
THYROID ABNORMALITIES AFTER THERAPEUTIC EXTERL RADIATION
, 1995
COMPUTED-TOMOGRAPHY ASSESSMENT OF SPLENIC SIZE AS A PREDICTOR OF SPLENIC WEIGHT AND DISEASE
, 1994
FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE
, 1993
CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS
, 1993
BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE
, 1993
THYROID-DISEASES AFTER TREATMENT OF HODGKINS-DISEASE
, 1991
INTERLEUKIN-1-BETA INITIALLY SENSITIZES AND SUBSEQUENTLY PROTECTS MURINE INTESTIL STEM-CELLS
, 1991
FIL REPORT OF THE PHASE-I TRIAL OF THE HYPOXIC CELL RADIOSENSITIZER SR-2508
, 1990
VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
, 1988
INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS
, 1988
Automatic prostate tracking
, 2013
Development and clinical evaluation of automatic fiducial detection for tumor tracking in cine
, 2013
Esophageal tolerance to high-dose stereotactic ablative radiotherapy
, 2012
Testicular Cancer Clinical Practice Guidelines in Oncology
, 2012
NCCN Clinical Practice Guidelines in Oncology for Kidney Cancer
, 2011
Clinical development of a failure detection-based online repositioning strategy for prostate IMRT
, 2010
Testicular Cancer
, 2009
Kidney Cancer
, 2009
Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's
, 2008
Radiotherapy after prostatectomy
, 2007
A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking.
, 2007
Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease
, 2007
Testicular cancer. Clinical practice guidelines in oncology.
, 2006
Kidney cancer. Clinical practice guidelines in oncology.
, 2006
Breast cancer screening in women surviving Hodgkin disease
, 2006
Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose
, 2006
Diastolic dysfunction after mediastinal irradiation
, 2005
Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality
, 2005
Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes
, 2005
Testicular cancer. Clinical practice guidelines.
, 2005
Kidney cancer. Clinical practice guidelines.
, 2005
A systolic murmur is a common presentation of aortic regurgitation detected by echocardiography
, 2004
Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes?
, 2004
Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy
, 2004
Asymptomatic cardiac disease following mediastinal irradiation
, 2003
Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI
, 2003
Role of beam orientation optimization in intensity-modulated radiation therapy
, 2001
Management of breast cancer after Hodgkin's disease
, 2000
Hodgkin's Lymphoma: Choice of Therapy and Late Complications.
, 2000
Fractionated stereotactic radiosurgery
, 1999
The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
, 1999
Radiation therapy for clinically localized prostate cancer - A multi-institutional pooled analysis
, 1999
Image-guided robotic radiosurgery
, 1999
Treatment of cavernous sinus tumors with linear accelerator radiosurgery
, 1999
Clinical experience with image-guided robotic radiosurgery
, 1998
Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma
, 1998
Clinical uses of radiosurgery
, 1998
Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator
, 1998
Effect of combined transient androgen deprivation and irradiation following radical prostatectomy
, 1998
Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
, 1998
Node-positive prostatic cancer: Taps or a call to arms?
, 1998
Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease
, 1997
Gastrointestinal cancer after treatment of Hodgkin's disease
, 1997
The cyberknife: A frameless robotic system for radiosurgery
, 1997
Linear accelerator-based stereotaxic radiosurgery for brain metastases
, 1996
Second cancers after Hodgkin's disease in childhood
, 1996
Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
, 1996
PROSTATE-SPECIFIC ANTIGEN AFTER RADIOTHERAPY FOR PROSTATE
, 1995
BRIEF CHEMOTHERAPY, STANFORD-V
, 1995
STEM-CELL FACTOR ENHANCES THE SURVIVAL OF MURINE INTESTINAL STEM-CELLS AFTER PHOTON IRRADIATION
, 1995
THYROID ABNORMALITIES AFTER THERAPEUTIC EXTERNAL RADIATION
, 1995
CONTROL OF PROSTATE-CANCER WITH RADIOTHERAPY - LONG-TERM RESULTS
, 1994
STEM-CELL FACTOR ENHANCES THE SURVIVAL OF IRRADIATED HUMAN BONE-MARROW MAINTAINED IN SCID MICE
, 1994
COMPUTED-TOMOGRAPHY ASSESSMENT OF SPLENIC SIZE AS A PREDICTOR OF SPLENIC WEIGHT AND DISEASE
, 1994
FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE
, 1993
THE EFFECT OF STEM-CELL FACTOR ON IRRADIATED HUMAN BONE-MARROW
, 1993
CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS
, 1993
BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE
, 1993
RADIATION OR SURGERY FOR CARCINOMA OF THE ESOPHAGUS - THE ROLE OF ORGAN-CONSERVING THERAPY
, 1993
THYROID-DISEASES AFTER TREATMENT OF HODGKINS-DISEASE
, 1991
INTERLEUKIN-1-BETA INITIALLY SENSITIZES AND SUBSEQUENTLY PROTECTS MURINE INTESTINAL STEM-CELLS
, 1991
FINAL REPORT OF THE PHASE-I TRIAL OF THE HYPOXIC CELL RADIOSENSITIZER SR-2508
, 1990
Current Stanford clinical trials for Hodgkin's disease.
, 1989
VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
, 1988
INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS
, 1988
What is Dr. Hancock's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Hancock's National Provider Identifier (NPI) number is 1821136631.
What common questions do patients ask about Dr. Hancock?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Hancock
What is Dr. Steven Hancock's specialty?
Dr. Hancock is a Radiation Oncologist near Palo Alto, CA.
What does a Radiation Oncologist do?
A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors.
Is this Dr. Steven Hancock affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Hancock is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Radiation Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Radiation Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Steven Hancock accepting new patients in Palo Alto, CA?
Yes, Dr. Steven Hancock is accepting new patients at this time.
Does Dr. Steven Hancock offer online booking?
Please contact Dr. Hancock's office at (650) 723-3391 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Steven Hancock?
Please contact Dr. Hancock's office at (650) 723-3391 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Steven Hancock have?
Dr. Steven Hancock is certified by the American Board of Radiology and American Board of Internal Medicine.
Other Radiation Oncologist Near Palo Alto, CA
Radiation Oncologist
Accepting patientsRadiation Oncologist
Accepting patients
Radiation Oncologist
Accepting patients